Pharmacologically increasing collateral perfusion during acute stroke using a carboxyhemoglobin gas transfer agent (Sanguinate™) in spontaneously hypertensive rats. by Prolong Pharma | May 1, 2018 | Publications
A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease by Prolong Pharma | Jan 1, 2018 | Publications
Prolong Completes Enrolling Patients in Phase 2 Trial of Sickle Cell Disease Therapy Sanguinate by Prolong Pharma | Dec 1, 2017 | News
Sanguinate™ (Pegylated carboxyhemoglobin bovine) improves cerebral blood flow to vulnerable brain regions at risk of delayed cerebral ischemia after subarachnoid hemorrhage. by Prolong Pharma | Dec 1, 2017 | Publications